MDRO in a facility, cohorting those with the same MDRO into dedicated units or areas of the facility is a strategy that is known to prevent transmission. MDRO targeted for cohorting include . Candida auris (C. auris), carbapenemase-producing organisms (CPO), and other emerging MDRO. 1. CDPH recommends obtaining carbapenemase-testing for all ...

MDRO colonization = identification of an MDRO at a body site with no signs or symptoms of infection; MDRO infection = clinical signs and symptoms of disease that are attributable to an MDRO that is isolated from a body

The California Department of Public Health is dedicated to optimizing the health and well-being of Californians. Skip to main content. en Español Contact Us About News & Media Jobs/Careers ...

Apr 12, 2024 · The Containment Strategy Guidelines that address novel and targeted MDROs, such as Candida auris and carbapenemase-producing Enterobacterales, Pseudomonas spp., and Acinetobacter are available on the Healthcare-Associated Infection (HAI) website.

Mar 10, 2025 · Select MDROs are required to be reported to LACDPH and the California Department of Public Health (CDPH). These include Candida auris, carbapenem-resistant Enterobacterales (CRE), carbapenemase-producing organisms (CPO), vancomycin-resistant Staphylococcus aureus (VRSA), and pan-nonsusceptible organisms. MDRO Reporting Overview

Mar 19, 2024 · The response strategies described in the Interim Guidance for a Public Health Response to Contain Novel or Targeted Multidrug-resistant Organisms (MDROs) are intended for pre-endemic stages of spread and are implemented following the identification of a targeted MDRO. They are time-limited and focused on facilities that have recently cared for ...

understanding of the epidemiology and transmission of MDRO in SNFs, CDPH updated Enhanced Standard Precautions to provide SNFs a more practical, resident-centered and activity-based approach for preventing MDRO transmission.

CDPH Cohorting Guidance • MDRO cohorts include patients or residents who are known to be infected or colonized with the same MDRO • Two types of MDRO cohorts can be implemented in a healthcare facility: • 1. A within-room cohort is where patients or residents with the same MDRO or carbapenemase (e.g., KPC, NDM) are placed within one room,

targeted MDROs may vary among different U.S. regions. Focus MDROs: The subset of targeted MDROs that the area public health jurisdiction has identified as the focus of their MDRO Prevention Plan. These are the MDROs for which outcomes will be measured and interventions (e.g., educational materials or colonization screening) will be directed.

(MDRO). CRPA and CRAB Epidemiology • CRPA and CRAB can be found in the healthcare environment (e.g., water, environmental surfaces, devices), and are naturally resistant to many antimicrobial drugs. 2-4 • CRPA and CRAB are highly transmissible in healthcare settings. Infected and colonized patients, as well as the environment can serve as